Paper Details

  1. Home
  2. Paper Details

A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients.

Author: BuhsmerJ P, BurkeJ F, DunnS R, GaughanW J, LissK A, MangoldA M, MichaelB

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This randomized controlled trial compared the efficacy of low-dose recombinant human erythropoietin (rHuEPO) alone and in combination with androgens for treating anemia in end-stage renal failure patients. The combination therapy significantly increased hematocrit levels compared to rHuEPO alone. While nandrolone decanoate was well tolerated, its long-term safety in this context requires further investigation.
Paper Details　
Original Abstract of the Article :
Two previous short-term studies (12 weeks and up to 16 weeks) that used androgens to supplement recombinant human erythropoietin (rHuEPO) for the treatment of the anemia associated with end-stage renal disease showed divergent results. Both studies were limited by their brief duration, since the hem...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1016/s0272-6386(97)90307-3

データ提供：米国国立医学図書館（NLM）

A Camel's Tale of Anemia Treatment

This study investigates the effectiveness of combining low-dose recombinant human erythropoietin (rHuEPO) with androgens for treating anemia in chronic hemodialysis patients. It's like discovering a new oasis in the desert, offering a potential solution to a persistent problem. The researchers conducted a 6-month trial to assess the efficacy of this combination therapy, carefully observing its effects on hematocrit levels and overall well-being.

A Camel's Perspective on Anemia Relief

The study's findings demonstrate that the combination of rHuEPO and androgens significantly increases hematocrit levels in chronic hemodialysis patients, offering a promising treatment for anemia. This approach, like a camel's resilience in navigating harsh landscapes, provides a solution for a challenging health condition.

From Oasis to Health: A Camel's Journey

This research highlights the potential of combination therapy for effectively treating anemia in chronic hemodialysis patients. It encourages further exploration of treatment options for this complex condition, potentially leading to improved quality of life for patients. This discovery is like finding a hidden spring of hope, offering a renewed sense of well-being for those struggling with anemia.

Dr. Camel's Conclusion

This study underscores the potential of combining rHuEPO and androgens for effectively treating anemia in chronic hemodialysis patients. The findings offer a promising treatment option for this complex condition, potentially leading to improved quality of life for patients. This discovery, like finding a hidden spring of hope in the desert, offers a renewed sense of well-being for those struggling with anemia.
Date :
  1. Date Completed 1997-10-23
  2. Date Revised 2019-08-15
Further Info :

Pubmed ID

9328363

DOI: Digital Object Identifier

10.1016/s0272-6386(97)90307-3

Related Literature

Article Analysis
・Side Effects of epoetin alfa injection
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.